The chart below shows the treatments the researchers planned to study.
Tacrolimus group Cyclosporin group
31 participants 31 participants
• Tacrolimus as a capsule • Cyclosporin as a capsule
by mouth by mouth
• SZC as a liquid by mouth • SZC as a liquid by mouth
• Treatment 1 once. This was • Treatment 1 once. This was
either tacrolimus on its own either cyclosporin on its own
or tacrolimus with SZC. or cyclosporin with SZC.
• Treatment 2 once, 2 weeks • Treatment 2 once,
later. This was whichever 2 weeks later. This was
treatment the participant whichever treatment the
had not yet taken. participant had not yet
taken.
What happened during this study?
The study started in March 2021 and ended in September 2021.
The participants were in the study for up to about 2 months. But, the entire
study took about 6 months to finish.
Before the participants took study treatment, they visited their study site
once. This part of the study lasted for up to 4 weeks. At this visit, the study
doctors made sure the participants could join the study. They also:
X did physical exams and asked about the participants’ medications and any
medical problems they were having
X took blood and urine samples
X checked the participants’ heart health using an electrocardiogram, also
called an “ECG”
X checked if the participants had COVID-19
5 | Clinical Study Results